The list also includes erythropoietin given to patients with chronic renal failure or oncological ailments, Humira®, Remicade® and Enbrel® in rheumatoid arthritis, psoriasis, and other immunological diseases. This evidence concerns the gene EPO and rheumatoid arthritis.